AXCELLA HEALTH INC's ticker is AXLA and the CUSIP is 05454B105. A total of 30 filers reported holding AXCELLA HEALTH INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1 | -100.0% | 2 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | -25.0% | 2 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -91.3% | 2 | -88.9% | 0.00% | – |
| Q1 2022 | $46,000 | -92.1% | 18 | -93.5% | 0.00% | – |
| Q4 2021 | $583,000 | -40.3% | 279 | -14.9% | 0.00% | – |
| Q3 2021 | $977,000 | -40.7% | 328 | -20.2% | 0.00% | – |
| Q2 2021 | $1,648,000 | -81.1% | 411 | -77.6% | 0.00% | – |
| Q1 2021 | $8,716,000 | -29.2% | 1,831 | -22.8% | 0.00% | – |
| Q4 2020 | $12,311,000 | -16.9% | 2,372 | -26.0% | 0.00% | – |
| Q3 2020 | $14,816,000 | +817.4% | 3,207 | +998.3% | 0.00% | – |
| Q2 2020 | $1,615,000 | -80.7% | 292 | -88.1% | 0.00% | – |
| Q1 2020 | $8,358,000 | +68.0% | 2,444 | +96.9% | 0.00% | – |
| Q4 2019 | $4,976,000 | +986.5% | 1,241 | +1432.1% | 0.00% | – |
| Q3 2019 | $458,000 | +518.9% | 81 | +912.5% | 0.00% | – |
| Q2 2019 | $74,000 | – | 8 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 8,748,414 | $81,448,000 | 3.52% |
| HARBOURVEST PARTNERS LLC | 1,229,034 | $11,442,000 | 2.14% |
| Artal Group S.A. | 389,741 | $3,628,000 | 0.15% |
| HealthCor Management, L.P. | 170,645 | $1,589,000 | 0.06% |
| Schonfeld Strategic Advisors LLC | 35,000 | $326,000 | 0.01% |
| Alyeska Investment Group, L.P. | 76,062 | $708,000 | 0.01% |
| KCL Capital, L.P. | 10,000 | $93,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 13,024 | $122,000 | 0.01% |
| FMR LLC | 3,380,000 | $29,095,000 | 0.00% |
| Squarepoint Ops LLC | 16,107 | $150,000 | 0.00% |